These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20972645)

  • 21. Effect of renin angiotensin system blockade on pentraxin 3 levels in type-2 diabetic patients with proteinuria.
    Yilmaz MI; Axelsson J; Sonmez A; Carrero JJ; Saglam M; Eyileten T; Caglar K; Kirkpantur A; Celik T; Oguz Y; Vural A; Yenicesu M; Lindholm B; Stenvinkel P
    Clin J Am Soc Nephrol; 2009 Mar; 4(3):535-41. PubMed ID: 19211665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial.
    Caironi P; Masson S; Mauri T; Bottazzi B; Leone R; Magnoli M; Barlera S; Mamprin F; Fedele A; Mantovani A; Tognoni G; Pesenti A; Gattinoni L; Latini R;
    Eur J Clin Invest; 2017 Jan; 47(1):73-83. PubMed ID: 27864924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of long-term (median 10.5 years) outcomes in children presenting with traumatic brain injury and an initial Glasgow Coma Scale score of 3 or 4.
    Fulkerson DH; White IK; Rees JM; Baumanis MM; Smith JL; Ackerman LL; Boaz JC; Luerssen TG
    J Neurosurg Pediatr; 2015 Oct; 16(4):410-9. PubMed ID: 26140392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality.
    Mauri T; Bellani G; Patroniti N; Coppadoro A; Peri G; Cuccovillo I; Cugno M; Iapichino G; Gattinoni L; Pesenti A; Mantovani A
    Intensive Care Med; 2010 Apr; 36(4):621-9. PubMed ID: 20119647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum caspase-3 levels and mortality are associated in patients with severe traumatic brain injury.
    Lorente L; Martín MM; Argueso M; Ramos L; Solé-Violán J; Riaño-Ruiz M; Jiménez A; Borreguero-León JM
    BMC Neurol; 2015 Nov; 15():228. PubMed ID: 26545730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated plasma level of pentraxin-3 predicts in-hospital and 30-day clinical outcomes in patients with non-ST-segment elevation myocardial infarction who have undergone percutaneous coronary intervention.
    Guo R; Li Y; Wen J; Li W; Xu Y
    Cardiology; 2014; 129(3):178-88. PubMed ID: 25323314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials.
    Latini R; Gullestad L; Masson S; Nymo SH; Ueland T; Cuccovillo I; Vårdal M; Bottazzi B; Mantovani A; Lucci D; Masuda N; Sudo Y; Wikstrand J; Tognoni G; Aukrust P; Tavazzi L;
    Eur J Heart Fail; 2012 Sep; 14(9):992-9. PubMed ID: 22740508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of a prognostic score for early mortality in severe head injury cases.
    Gómez PA; de-la-Cruz J; Lora D; Jiménez-Roldán L; Rodríguez-Boto G; Sarabia R; Sahuquillo J; Lastra R; Morera J; Lazo E; Dominguez J; Ibañez J; Brell M; de-la-Lama A; Lobato RD; Lagares A
    J Neurosurg; 2014 Dec; 121(6):1314-22. PubMed ID: 25237737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum substance P levels are associated with severity and mortality in patients with severe traumatic brain injury.
    Lorente L; Martín MM; Almeida T; Hernández M; Ramos L; Argueso M; Cáceres JJ; Solé-Violán J; Jiménez A
    Crit Care; 2015 Apr; 19(1):192. PubMed ID: 25928056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased levels of serum pentraxin 3, a novel cardiovascular biomarker, in patients with inflammatory rheumatic disease.
    Hollan I; Bottazzi B; Cuccovillo I; Førre ØT; Mikkelsen K; Saatvedt K; Almdahl SM; Mantovani A; Meroni PL;
    Arthritis Care Res (Hoboken); 2010 Mar; 62(3):378-85. PubMed ID: 20391484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum pentraxin 3 is a novel marker in Crohn's disease.
    Chen J; Xu X; Xia L; Xi X; Liu B; Yang M
    Mol Med Rep; 2015 Jul; 12(1):543-6. PubMed ID: 25760650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon-α coincides with suppressed levels of pentraxin-3 (PTX3) in systemic lupus erythematosus and regulates leucocyte PTX3 in vitro.
    Wirestam L; Enocsson H; Skogh T; Eloranta ML; Rönnblom L; Sjöwall C; Wetterö J
    Clin Exp Immunol; 2017 Jul; 189(1):83-91. PubMed ID: 28257596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma levels of oxidative stress biomarkers and hospital mortality in severe head injury: a multivariate analysis.
    Hohl A; Gullo Jda S; Silva CC; Bertotti MM; Felisberto F; Nunes JC; de Souza B; Petronilho F; Soares FM; Prediger RD; Dal-Pizzol F; Linhares MN; Walz R
    J Crit Care; 2012 Oct; 27(5):523.e11-9. PubMed ID: 21803537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between serum tissue inhibitor of matrix metalloproteinase-1 levels and mortality in patients with severe brain trauma injury.
    Lorente L; Martín MM; López P; Ramos L; Blanquer J; Cáceres JJ; Solé-Violán J; Solera J; Cabrera J; Argueso M; Ortiz R; Mora ML; Lubillo S; Jiménez A; Borreguero-León JM; González A; Orbe J; Rodríguez JA; Páramo JA
    PLoS One; 2014; 9(4):e94370. PubMed ID: 24728097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors Associated with Arterial Stiffness in Chronic Hemodialysis Patients in Jakarta: The Role of Hemodialysis Frequency and Pentraxin 3.
    Wardoyo EY; Nainggolan G; Hustrini NM; Setiati S
    Acta Med Indones; 2021 Apr; 53(2):177-183. PubMed ID: 34251346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma Pentraxin 3 Is Closely Associated with Peripheral Arterial Disease in Hemodialysis Patients and Predicts Clinical Outcome: A 6-Year Follow-Up.
    Zhou Y; Zhang J; Zhu M; Lu R; Wang Y; Ni Z
    Blood Purif; 2015; 39(4):266-73. PubMed ID: 25924996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients.
    Muller B; Peri G; Doni A; Torri V; Landmann R; Bottazzi B; Mantovani A
    Crit Care Med; 2001 Jul; 29(7):1404-7. PubMed ID: 11445697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Matrix metalloproteinase 9 and cellular fibronectin plasma concentrations are predictors of the composite endpoint of length of stay and death in the intensive care unit after severe traumatic brain injury.
    Copin JC; Rebetez MM; Turck N; Robin X; Sanchez JC; Schaller K; Gasche Y; Walder B
    Scand J Trauma Resusc Emerg Med; 2012 Dec; 20():83. PubMed ID: 23249478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma PTX3 levels in sickle cell disease patients, during vaso occlusion and acute chest syndrome (data from Saudi population).
    Elshazly SA; Heiba NM; Abdelmageed WM
    Hematology; 2014 Jan; 19(1):52-9. PubMed ID: 23735470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term prognostic significance of pentraxin-3 in patients with acute myocardial infarction: 5-year prospective cohort study.
    Altay S; Çakmak HA; Kemaloğlu Öz T; Özpamuk Karadeniz F; Türer A; Erer HB; Kılıç GF; Keleş İ; Can G; Eren M
    Anatol J Cardiol; 2017 Mar; 17(3):202-209. PubMed ID: 27488759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.